Sustained MK-801 induced deficit in a novel probabilistic reversal learning task

Patrick Latuske1, Moritz von Heimendahl1, Serena Deiana1

  • 1Central Nervous System Diseases Research, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riß, Germany.

Frontiers in Pharmacology
|October 31, 2022
PubMed
Summary

A new time-based probabilistic reversal learning (PRL) task in rats shows improved sensitivity to cognitive flexibility deficits. This enhanced method aids in preclinical drug development for neuropsychiatric disorders.

Related Concept Videos